| Secondary |
| Product Used For Unknown Indication |
31.9% |
| Drug Use For Unknown Indication |
16.1% |
| Hyperthyroidism |
14.0% |
| Breast Cancer |
4.5% |
| Basedow's Disease |
3.6% |
| Thrombosis Prophylaxis |
3.6% |
| Hypertension |
3.0% |
| Insomnia |
2.7% |
| Agitation |
2.4% |
| Anxiety |
2.4% |
| Sinus Tachycardia |
2.4% |
| Urinary Tract Infection |
2.4% |
| Osteoarthritis |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Bipolar Disorder |
1.5% |
| Febrile Neutropenia |
1.5% |
| Lung Infection |
1.2% |
| Malignant Melanoma |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Angina Pectoris |
0.9% |
|
| Neutropenia |
17.6% |
| Renal Failure Acute |
11.8% |
| Leukopenia |
7.8% |
| Metabolic Alkalosis |
5.9% |
| Thrombocytopenia |
5.9% |
| Tonsillitis |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Bronchitis |
3.9% |
| Cardiac Failure |
3.9% |
| Hepatic Steatosis |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Platelet Count Decreased |
3.9% |
| Somnolence |
3.9% |
| Swelling Face |
3.9% |
| Autoimmune Hepatitis |
2.0% |
| Blood Glucose Increased |
2.0% |
| Blood Lactate Dehydrogenase Increased |
2.0% |
| Cardiac Failure Acute |
2.0% |
| Chronic Hepatitis |
2.0% |
| Cytolytic Hepatitis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.0% |
| Hepatitis C |
11.0% |
| Hypertension |
9.8% |
| Hyperthyroidism |
8.9% |
| Prophylaxis |
6.5% |
| Atrial Fibrillation |
6.3% |
| Diabetes Mellitus |
6.2% |
| Adult T-cell Lymphoma/leukaemia |
5.4% |
| Drug Use For Unknown Indication |
4.4% |
| Basedow's Disease |
3.9% |
| Cardiac Failure |
3.2% |
| Stomatitis |
3.0% |
| Constipation |
2.6% |
| Insomnia |
2.4% |
| Depression |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Arrhythmia |
2.0% |
| Breast Cancer |
2.0% |
| Anxiety |
1.8% |
| Transplant Rejection |
1.8% |
|
| Malaise |
9.5% |
| Vomiting |
7.1% |
| Anaemia |
6.0% |
| Renal Failure |
6.0% |
| Urticaria |
6.0% |
| Blood Alkaline Phosphatase Increased |
4.8% |
| Cardiac Failure |
4.8% |
| Diarrhoea |
4.8% |
| Drug Effect Decreased |
4.8% |
| Interstitial Lung Disease |
4.8% |
| Myocardial Infarction |
4.8% |
| Palpitations |
4.8% |
| Respiratory Failure |
4.8% |
| Transaminases Increased |
4.8% |
| Urinary Tract Infection |
4.8% |
| Bradycardia |
3.6% |
| Drug Ineffective |
3.6% |
| Hyponatraemia |
3.6% |
| Nausea |
3.6% |
| Oedema Peripheral |
3.6% |
|
| Interacting |
| Hypertension |
50.0% |
| Dyslipidaemia |
25.0% |
| Toxic Nodular Goitre |
25.0% |
|
|
